Asklepios BioPharmaceutical

Affinia Therapeutics

This company develops rationally designed gene therapies and viral vectors for patients with heart and central nervous system diseases.

AveXis

This biotechnology firm develops gene therapies for patients with rare and life-threatening neurological genetic diseases including spinal muscular atrophy.

Lexeo Therapeutics

This clinical-stage company develops gene therapies for patients with genetically defined cardiovascular diseases and Alzheimer's disease.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Audentes Therapeutics

The company develops gene therapy products to treat patients with serious and rare neuromuscular diseases.

Prevail Therapeutics

The company develops adeno-associated virus gene therapies to treat patients with neurodegenerative conditions including Parkinson's disease and frontotemporal dementia.

Forge Biologics

This company provides adeno-associated virus manufacturing services and develops gene therapies for biotechnology and pharmaceutical organisations.

AavantiBio

This digital health company develops gene transfer therapies for patients with rare genetic conditions including Friedreich's ataxia and cardiac diseases.